الانتقال الى المحتويات

علم الأورام (طب الأطفال)

النتائج السريرية

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531. (يفتح نافذة جديدة)

Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, Hirsch BA, Kahwash SB, Heerema-McKenney A, Winter L, Glick K, Davies SM, Byron P, Smith FO, Aplenc R

Source‎: J Clin Oncol 2014;32(27):3021-32.

مفهرسة‎: PubMed 25092781

DOI‎: 10.1200/JCO.2014.55.3628

https://www.ncbi.nlm.nih.gov/pubmed/25092781 (يفتح نافذة جديدة)

Red blood cell transfusion and outcome in cancer. (يفتح نافذة جديدة)

Iqbal N, Haider K, Sundaram V, Radosevic J, Burnouf T, Seghatchian J, Goubran H

Source‎: Transfus Apher Sci 2017;56(3):287-90.

مفهرسة‎: PubMed 28602484

DOI‎: 10.1016/j.transci.2017.05.014

https://www.ncbi.nlm.nih.gov/pubmed/28602484 (يفتح نافذة جديدة)

Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases. (يفتح نافذة جديدة)

Oh SY, Kim SH, Kwon HC, Lee S, Kim KH, Kwon KA, Lee JH, Lee KY, Kim HJ

Source‎: Support Care Cancer 2010;18(10):1341-6.

مفهرسة‎: PubMed 19841950

DOI‎: 10.1007/s00520-009-0759-3

https://www.ncbi.nlm.nih.gov/pubmed/19841950 (يفتح نافذة جديدة)